Alternative image

B4U™ microbial strain library

The human microbiome consists of trillions of microorganisms that affect not only the gut, but the health of the entire body and our overall well-being. For example, the gut microbiome affects the immune system, skin, metabolism, and brain far beyond digestion. As more people become aware of the central role the gut microbiome plays in our overall health, there is growing interest in how diet and nutrition can positively influence our microbiome. As a result, there is a growing demand for microbiotic products such as prebiotics and probiotic supplements. 

Our B4U™ brand of bacterial strains from our extensive strain library allows you to create foods, food supplements or FSMPs (food for special medical purposes) for microbiome health. The health benefits of our probiotics have been scientifically researched and clinically tested in innovative synbiotic combinations. Use our B4U™ quality strains for value-added differentiation of your individual products.

Evonik's B4U™ bacterial strains can be used for probiotic nutraceuticals, dietary & food supplements or FSMP and are clinically tested in innovative synbiotic solutions.

Spore-forming bacterial strains

Spore formers are very robust, which makes them easy to process. Our spores are suitable for a variety of formulations: as a powder for sports nutrition or dietary supplements, for filling into capsules or for processing into fruit gums. Their stability ensures long shelf life in products. Spore-forming bacterial cultures are also highly resistant to gastric and bile acids in the digestive tract.

Evonik's B4U™ spore-forming bacterial strains can be used for probiotic nutraceuticals, dietary & food supplements or FSMP and are clinically tested in innovative synbiotic solutions.

At Evonik, we have many years of experience in the development of spore products, such as spore-based probiotics, and will be happy to advise you.

Alternative image

Our B4U™ microbial strains

Target areas

  • Intestine
  • Immune system
  • Metabolism
  • Gut-brain axis
Evonik's B4U™21 strain - Bacillus subtilis DSM 32315 spore powder

Strain properties

  • Tested to the EFSA safety standard/QPS status
  • Heat and process stability
  • Gastric and bile acid resistance
  • Inhibitory to many known pathogens
  • Produces large amounts of lactic acid
  • Causes an increase in butyrate levels in the gut
  • Promotes butyrate-forming bacteria
  • Has been clinically studied for its effect on glucose metabolism and lipid levels

The B4U™21 strain was investigated in pre-clinical and clinical studies

Target areas

  • Intestine
  • Micro-inflammatory processes
Evonik's B4U™63 strain - Bacillus megaterium DSM 32963 spore powder

Strain properties

  • Tested to the EFSA safety standard/QPS status
  • Heat and process stability
  • Gastric and bile acid resistance
  • Specialized pro-resolving mediator (SPM) producer: converts omega-3 fatty acids into anti-inflammatory lipids
  • Has been studied in clinical trials for its effect on SPM formation

The B4U™63 strain was investigated in preclinical and clinical studies

Did you know?

We also use our B4U™ quality strains in our innovative synbiotic combinations marketed under IN VIVO BIOTICS™. 

Evonik's B4U™ bacterial strains are being used in IN VIVO BIOTICS™ synbiotic combinations

Alternative image
Does your company want to bring dietary supplements to the next level? Are you interested in finding out more about our solutions?
Susanne Pluta (Director Consumer Products)

General disclaimer 

The content of this website is intended for healthcare professionals and business customers only. This content is not intended for end users of such products. None of the statements on this website should be taken as an approved health claim.

These claims have not been evaluated by EFSA. This product is not intended to diagnose, treat, cure or prevent any disease.

These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure or prevent any disease.